FCX vs XGN · P/E 38, rev $13.26B vs rev $37.2M
Freeport-McMoran Copper & Gold Inc (FCX) versus Exagen Inc (XGN) — a side-by-side from cached financials, not a winner call.
Freeport-McMoran Copper & Gold Inc (FCX) is a copper company listed on US.
Exagen Inc (XGN) is a diagnostics & research company listed on US.
Latest reported FCX revenue for 2026-06-30 was $13.26B. Net income was $1.86B. FCX currently screens at market cap $67.80B and trailing P/E 38.0.
Latest reported XGN revenue for 2026-06-30 was $37.2M. Net income was -$7.2M. XGN currently screens at market cap $154.1M.
FCX currently screens at market cap $67.80B and trailing P/E 38.0. XGN currently screens at market cap $154.1M.
Not investment advice. Open the FCX and XGN stock pages for the full models.
Not investment advice.